Skip to main content
. Author manuscript; available in PMC: 2013 Jun 19.
Published in final edited form as: Psychoneuroendocrinology. 2011 May 20;36(10):1540–1552. doi: 10.1016/j.psyneuen.2011.04.008

Table 2.

Startle magnitude across groups and dexamethasone (DEX) treatment conditions across the three blocks of conditioning.

Startle magnitude (μV) PTSD (n = 33)
No-PTSD (n = 67)
No DEX TMT (n = 16) DEX TMT (n = 17) No DEX TMT (n = 38) DEX TMT (n = 29)
Block 1
Noise alone (M, SE) 131.71 (27.0) 69.82 (26.2) 72.43 (17.5) 74.05 (20.1)
CS+ (M, SE) 164.84 (31.2) 100.39 (30.3) 113.83 (20.3) 107.08 (23.2)
CS− (M, SE) 190.54 (32.0) 104.45 (31.1) 107.65 (20.8) 116.85 (23.8)
Block 2
Noise alone (M, SE) 104.34 (21.1) 59.89 (20.5) 58.52 (13.7) 65.31 (15.7)
CS+ (M, SE) 182.53 (30.4) 96.32 (29.5), 112.70 (19.7) 102.29 (22.6)
CS− (M, SE) 171.70 (30.1) 94.59 (29.2) 83.39 (19.5)* 91.93 (22.4)
Block 3
Noise alone (M, SE) 99.41 (23.0) 51.75 (22.3) 51.62 (14.9) 46.05 (17.1)
CS+ (M, SE) 183.92 (30.4) 79.90 (29.8), 80.36 (19.9),* 91.81 (22.8)
CS− (M, SE) 138.31 (23.3) 72.85 (22.6) 58.11 (15.1)* 58.81 (17.3)
*

Diagnostic group effect, p < 0.05.

Trial type effect (CS+ vs. NA), p < 0.05.

DEX treatment effect, p < 0.05.